Sponsors (4)
Introduced March 19, 2026 by Betty McCollum · Last progress March 19, 2026
The bill significantly reduces PFAS exposure and strengthens enforcement, transparency, and research support—especially benefiting impacted communities—but does so by imposing substantial compliance costs, expanded liability and legal risks, and budget pressures on manufacturers, small businesses, and state/local governments.
Consumers (especially children, pregnant people, and low-income communities) will face fewer PFAS-containing products because the bill phases out and bans many PFAS uses, reducing long-term exposure and related health risks.
Communities with PFAS contamination (including low-income and rural communities) gain stronger enforcement and response tools—EPA injunctions/penalties, mandatory public notice, and community meetings—to compel cleanup and protect public health.
The bill increases transparency: manufacturers must report PFAS uses, volumes, releases, and exposure estimates and make information available for public review, improving oversight and enabling communities and regulators to act.
Manufacturers, importers, retailers, and small businesses face substantial new compliance, reporting, reformulation, phaseout, and monitoring costs that are likely to raise prices for consumers and strain small firms.
The bill increases legal and financial risk for companies and officials—large daily penalties, high default fees for petitions/reports, criminal liability for reckless violations, and extended CERCLA-related liability and bankruptcy limits—raising litigation exposure and potential financial ruin for some businesses.
State and local governments and utilities will bear significant monitoring, remediation, and compliance costs (and may face funding uncertainty), potentially straining budgets and diverting resources from other priorities.
Based on analysis of 4 sections of legislative text.
Directs EPA to define and phase out nonessential PFAS uses, commissions the National Academies to review essential uses, creates Centers of Excellence for PFAS research, and adds civil and criminal enforcement powers.
Requires the EPA to define and phase out nonessential uses of per- and polyfluoroalkyl substances (PFAS), hire the National Academies to review which uses are essential and recommend priorities for phaseout, create Centers of Excellence to improve PFAS detection and remediation research (including a rural center), and give EPA civil and criminal enforcement powers and compliance tools against unlawful PFAS uses. It sets definitions, timelines for scientific review, criteria for selecting research centers, and penalties for noncompliance.